Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trials

Medical device clinical trials from ClinicalTrials.gov

Trial ENROLLING_BY_INVITATION

A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB

NCT NCT05635747

Last updated: 2026-07-06

View Details →

Trial COMPLETED

Evaluation of a Therapeutic Mobile App for Depression

NCT NCT05601362

Last updated: 2026-07-06

View Details →

Trial ACTIVE_NOT_RECRUITING

Lumbar Fusion With Porous Versus Non-Porous Cages

NCT NCT05583864

Last updated: 2026-07-06

View Details →

Trial RECRUITING

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

NCT NCT05496998

Last updated: 2026-07-06

View Details →

Trial RECRUITING

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

NCT NCT05378347

Last updated: 2026-07-06

View Details →

Trial RECRUITING

Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients

NCT NCT05283811

Last updated: 2026-07-06

View Details →

Trial TERMINATED

DIAMOND AF Post-Approval Study

NCT NCT05230524

Last updated: 2026-07-06

View Details →

Trial ACTIVE_NOT_RECRUITING

Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury

NCT NCT05218447

Last updated: 2026-07-06

View Details →

Trial ENROLLING_BY_INVITATION

Investigation of the Duration of Low-intensity Focused Ultrasound

NCT NCT05147103

Last updated: 2026-07-06

View Details →

Trial ACTIVE_NOT_RECRUITING

Screening for High Frequency Malignant Disease

NCT NCT05117840

Last updated: 2026-07-06

View Details →

Trial RECRUITING

St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

NCT NCT05092022

Last updated: 2026-07-06

View Details →

Trial RECRUITING

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

NCT NCT04968964

Last updated: 2026-07-06

View Details →

Page 360 of 834

↑